At close: January 6 at 2:07:23 PM EST
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
3,479.5330
3,286.0440
5,521.0130
17,833.0260
18,592.4540
Operating Income
-3,479.5330
-3,286.0440
-5,521.0130
-17,833.0260
-18,592.4540
Net Non Operating Interest Income Expense
16.2140
38.6900
64.6130
52.8000
17.7520
Other Income Expense
-2,237.1920
-2,371.2680
-864.5000
-26.7010
-1,544.1000
Pretax Income
-5,700.5110
-5,618.6220
-6,320.9000
-17,806.9270
-20,118.8020
Net Income Common Stockholders
-5,700.5110
-5,618.6220
-6,320.9000
-17,806.9270
-20,118.8020
Diluted NI Available to Com Stockholders
-5,700.5110
-5,618.6220
-6,320.9000
-17,806.9270
-20,118.8020
Basic EPS
-0.01
-0.01
-0.02
-0.06
-0.08
Diluted EPS
-0.01
-0.01
-0.02
-0.06
-0.08
Basic Average Shares
395,712.4780
380,483.1210
339,370.6350
319,763.9660
267,491.0890
Diluted Average Shares
395,712.4780
380,483.1210
339,370.6350
319,763.9660
267,491.0890
Total Expenses
3,479.5330
3,286.0440
5,521.0130
17,833.0260
18,592.4540
Net Income from Continuing & Discontinued Operation
-5,700.5110
-5,618.6220
-6,320.9000
-17,806.9270
-20,118.8020
Normalized Income
-3,463.3190
-3,247.3540
-5,456.4000
-17,780.2260
-18,574.7020
Interest Income
31.9820
61.9780
112.7850
123.1630
103.0790
Interest Expense
13.2460
20.0950
43.9970
63.4230
78.9820
Net Interest Income
16.2140
38.6900
64.6130
52.8000
17.7520
EBIT
-5,687.2650
-5,598.5270
-6,276.9030
-17,743.5040
-20,039.8200
EBITDA
-5,686.9570
-5,598.1990
-6,276.4690
-17,742.9260
-20,039.0450
Reconciled Depreciation
0.3080
0.3280
0.4340
0.5780
0.7750
Net Income from Continuing Operation Net Minority Interest
-5,700.5110
-5,618.6220
-6,320.9000
-17,806.9270
-20,118.8020
Total Unusual Items Excluding Goodwill
-2,237.1920
-2,371.2680
-864.5000
-26.7010
-1,544.1000
Total Unusual Items
-2,237.1920
-2,371.2680
-864.5000
-26.7010
-1,544.1000
Normalized EBITDA
-3,449.7650
-3,226.9310
-5,411.9690
-17,716.2250
-18,494.9450
6/30/2021 - 7/12/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TRIP.CN Red Light Holland Corp.
0.0450
+12.50%
PHRX.CN Pharmadrug Inc.
0.0150
0.00%
MYCO.CN Mydecine Innovations Group Inc.
0.0100
+100.00%
PWR.CN Captiva Verde Wellness Corp.
0.0350
-12.50%
LMLLF Pharmadrug Inc.
0.0107
0.00%
AION.CN Aion Therapeutic Inc.
0.0100
0.00%
VENI.CN Vencanna Ventures Inc.
0.0100
-33.33%
FFNT.CN 4Front Ventures Corp.
0.0200
-20.00%
OPTI.CN Optimi Health Corp.
0.2100
-8.70%
BCBC.CN The BC Bud Corporation
0.0800
0.00%